Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle.

摘要

Carbamate esters of eseroline having anticholinesterase activity characterized by the following formula (I): <CHEM> wherein W is a substituent, as defined in the following Specification, HY is a pharmaceutically acceptable organic or inorganic acid x may be 0, 1, 2 and 3 in case of monofunctional acids provided that x is 3 only when W is <CHEM> or 1/2 and 1/3 in case of bifunctional or trifunctional acids, a process for their preparation and pharmaceutical compositions containing said compounds , as the active principles, for the treatment of diseases associated with cholinergic disorders.